Crsp stock forecast 2025.

According to our CRISPR Therapeutics AG stock prediction for 2025, CRSP stock will be priced at $ 114.05 in 2025. This forecast is based on the stock’s average …

Crsp stock forecast 2025. Things To Know About Crsp stock forecast 2025.

Shares of CRISPR Therapeutics ( CRSP -7.40%) sank 50.5% in 2021, according to data from S&P Global Market Intelligence. After surging roughly 151% across 2020's trading, investors reassessed the ...According to 42 stock analysts, the average 12-month stock price forecast for Amazon stock is $170.76, which predicts an increase of 16.14%. The lowest target is $116 and the highest is $230. On average, analysts rate Amazon stock as a strong buy.Based on short-term price targets offered by 37 analysts, the average price target for CrowdStrike Holdings comes to $201.46. The forecasts range from a low of $162.00 to a high of $245.00. The ...Target values for the price of one Luminar Technologies share for Mar 2025. The weighted average target price per Luminar Technologies share in Mar 2025 is: 2.61. In Mar, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 15.345% volatility is expected. Pessimistic target level: 2.42.Stock Price Forecast. The 22 analysts offering 12-month price forecasts for CRISPR Therapeutics AG have a median target of 81.00, with a high estimate of 220.00 and a low estimate of 42.00. The median estimate represents a +17.27% increase from the …

Nikola Corp () Stock Market info Recommendations: Buy or sell Nikola stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Nikola share forecasts, stock quote and buy / sell signals below.According to present data Nikola's NKLA shares and potentially its market environment have been in bearish cycle last 12 …The latest CRISPR Therapeutics stock prices, stock quotes, news, and CRSP history to help you invest and trade smarter. ... The 68 analysts offering price forecasts for CRISPR Therapeutics have a ...Since bonds and stocks compete for investors' dollars, a higher yield typically needs to be paid to the stock investor for the extra risk being assumed vs. the virtual risk-free investment offered ...

The weighted average target price per CRISPR Therapeutics share in Dec 2023 is: 68.02. In Dec, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 15.330% volatility is expected. CRISPR Therapeutics stock price predictions for 2023 using artificial intelligence.Traders Union experts conducted a comprehensive analysis and predicted that by the end of 2024 Google price will hit $179.92. Google will grow to $200.9 in 2025, $279.67 in 2028 and $348.68 in 2030. Traders Union analysts have prepared a selection of analytical forecasts from top portals for 2024, 2025, 2030.

We asked three Motley Fool contributors to pick beaten-down stocks they think can deliver 5x gains by 2030. Here's why they chose CRISPR Therapeutics ( CRSP -0.74%), Ginkgo Bioworks Holdings ( DNA ...MERCERWISE 2025 TARGET DATE C- Performance charts including intraday, historical charts and prices and keydata. Indices Commodities Currencies StocksAmazon Stock Forecast 12-07-2023. Forecast target price for 12-07-2023: $ 150.20. Positive dynamics for Amazon shares will prevail with possible volatility of 1.272%. Pessimistic target level: 149.24. Optimistic target level: 151.16.KYN Capital Group Inc () Stock Market info Recommendations: Buy or sell KYN Capital Group stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the KYN Capital Group share forecasts, stock quote and buy / sell signals below.According to present data KYN Capital Group's KYNC shares and potentially its …

Oct 15, 2020 · Palantir Technologies Inc - Class A (PLTR) stock price prediction is 15.953138725275 USD. The Palantir Technologies Inc - Class A stock forecast is 15.953138725275 USD for 2024 December 01, Sunday with technical analysis.

Unraveling CRISPR Therapeutics (CRSP) Stock Predictions for 2024 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing CRISPR Therapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts.

Traders Union experts conducted a comprehensive analysis and predicted that by the end of 2024 Google price will hit $179.92. Google will grow to $200.9 in 2025, $279.67 in 2028 and $348.68 in 2030. Traders Union analysts have prepared a selection of analytical forecasts from top portals for 2024, 2025, 2030.12/02/2023. Palantir stock price stood at $20.27. According to the latest long-term forecast, Palantir price will hit $25 by the end of 2023 and then $30 by the middle of 2025. Palantir will rise to $45 within the year of 2026, $55 in 2027, $60 in 2028, $65 in 2029, $70 in 2030, $75 in 2032, $80 in 2033, $85 in 2034 and $90 in 2035.Nov 25, 2023 · CRISPR Therapeutics stock prediction for June 2025. In the beginning at 81.08. Maximum 90.30, minimum 76.92. The averaged price 82.98. At the end of the month 83.61 dollars, change for June 3.1%. CRISPR Therapeutics stock price forecast for July 2025. In the beginning at 83.61. Maximum 92.20, minimum 78.54. The averaged price 84.93. CRISPR Therapeutics Future Growth Future criteria checks 2/6 CRISPR Therapeutics is forecast to grow earnings and revenue by 46.4% and 48.2% per annum …

Oct 15, 2020 · CRISPR Therapeutics AG (CRSP) stock price prediction is 130.64207402132 USD. The CRISPR Therapeutics AG stock forecast is 130.64207402132 USD for 2024 November 24, Sunday; and 586.145 USD for 2028 November 24, Friday with technical analysis. The CRISPR Therapeutics stock price gained 2.88% on the last trading day (Friday, 1st Dec 2023), rising from $66.73 to $68.65. During the last trading day the stock fluctuated 8.38% from a day low at $63.39 to a day high of $68.70. The price has been going up and down for this period, and there has been a 15.92% gain for the last 2 weeks.In 2025, CRSR is forecast to generate $199,868,015,215 in revenue, with the lowest revenue forecast at $199,868,015,215 and the highest revenue forecast at $199,868,015,215. ... with the highest CRSR stock price forecast at $21.00 and the lowest CRSR stock price forecast at $14.00.On average, Wall Street analysts predict. that …Vortex Energy Corp () Stock Market info Recommendations: Buy or sell Vertex Pharmaceuticals stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Vertex Pharmaceuticals share forecasts, stock quote and buy / sell signals below.According to present data Vertex Pharmaceuticals's VRTX shares and …All stock predictions. Overall outlook for CRISPR Therapeutics stock. 2023. ... (CRSP) stock consensus forecasts for 2025. Last update: 06/17/2023, 02:26 AM Brief ...CRSP - CRISPR Therapeutics Stock Prediction 2025 - 2030 + Portfolio 7 years of reliable CRISPR Therapeutics stock forecast. The Wall Street analysts predict Outperform for CRSP. See at a glance whether NasdaqGM:CRSP will rise in the future. $41.47 Forecast 2023 $49.60 Forecast 2025 $77.58 Forecast 2030 Underperform TopGraphs Quality RankingCRISPR Therapeutics AG analyst ratings, historical stock prices, earnings estimates & actuals. CRSP.US updated stock price target summary ... FY 2025. CRSP will ...

The average TDOC stock price target stood at $124.77 a share, resulting in a potential 64% upside based on the last closing price of $75.86 (as of 28 February). The highest 12-month Teladoc share price forecast was $215, while the lowest was set at $67. Right after the company announced its results for the fourth quarter of the 2021 fiscal …

The CRISPR Therapeutics stock price gained 2.88% on the last trading day (Friday, 1st Dec 2023), rising from $66.73 to $68.65. During the last trading day the stock fluctuated 8.38% from a day low at $63.39 to a day high of $68.70. The price has been going up and down for this period, and there has been a 15.92% gain for the last 2 weeks.Target values for the price of one CRISPR Therapeutics share for Feb 2026. The weighted average target price per CRISPR Therapeutics share in Feb 2026 is: 39.08. In Feb, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 15.704% volatility is expected. Pessimistic target level: 35.58.CRISPR Therapeutics stock prediction for June 2025. In the beginning at 81.08. Maximum 90.30, minimum 76.92. The averaged price 82.98. At the end of the month 83.61 dollars, change for June 3.1%. CRISPR Therapeutics stock price forecast for July 2025. In the beginning at 83.61. Maximum 92.20, minimum 78.54. The averaged price 84.93.Cash and securities were $1.9 billion as of March 31, 2023 and net loss was only $53.1 million for Q1 2023, so there is no danger of dilution in the near future. Under the Vertex Joint Development ...Find real-time SHEL - Shell PLC stock quotes, company profile, news and forecasts from CNN Business.AA Stock 12 Months Forecast. $28.05. (6.49% Upside) Based on 10 Wall Street analysts offering 12 month price targets for Alcoa in the last 3 months. The average price target is $28.05 with a high forecast of $41.00 and a low forecast of $14.00. The average price target represents a 6.49% change from the last price of $26.34.CRISPR Therapeutics AG Stock Forecast, CRSP stock price prediction. Price target in 14 days: 83.094 USD. ... CRISPR Therapeutics AG Stock Price Forecast for 2025 ...

Be the first to know when Wall Street analysts revise their CRWD stock forecasts and price targets. Get Free CRWD Updates. CRWD stock forecasts by analyst. All ... On average, 13 Wall Street analysts forecast CRWD's revenue for 2025 to be $933,992,560,162, with the lowest CRWD revenue forecast at $920,170,065,158, and the highest CRWD revenue ...

Nov 30, 2023 · Based on short-term price targets offered by 22 analysts, the average price target for CRISPR Therapeutics AG comes to $89.77. The forecasts range from a low of $42.00 to a high of $220.00. The ...

Nov 14, 2023 · The share price of CRISPR Therapeutics AG (CRSP) now. What analysts predict: $88.13. 52-week High/Low: $72 / $37.55. 50/200 Day Moving Average: $45.85 / $51.4. This figure corresponds to the Average Price over the previous 50/200 days. For CRISPR Therapeutics stocks, the 50-day moving average is the support level today. General Motors Company () Stock Market info Recommendations: Buy or sell General Motors stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the General Motors share forecasts, stock quote and buy / sell signals below.According to present data General Motors's GM shares and potentially its market …MERCERWISE 2025 TARGET DATE C- Performance charts including intraday, historical charts and prices and keydata. Indices Commodities Currencies StocksStock Price Forecast. The 7 analysts offering 12-month price forecasts for Corsair Gaming Inc have a median target of 17.00, with a high estimate of 21.00 and a low estimate of 14.00. The median ...The mean of analysts' price targets for CRISPR Therapeutics AG (CRSP) points to a 33.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ...Nov 19, 2023 · CRISPR Therapeutics Stock Up 14.6 %. NASDAQ:CRSP opened at $67.89 on Friday. The company’s 50 day moving average price is $46.64 and its 200-day moving average price is $53.09. CRISPR Therapeutics has a 52 week low of $37.55 and a 52 week high of $72.00. The stock has a market cap of $5.39 billion, a price-to-earnings ratio of -15.19 and a ... Forecast target price for 10-29-2023: $41.07. Positive dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 2.788%. Pessimistic ...The Trimble stock forecast is 92.58442711926 USD for 2024 November 09, Saturday; and 383.563 USD for 2028 November 09, Thursday with technical analysis. Trimble (TRMB) stock price prediction is 92.58442711926 USD.

CRISPR Therapeutics AG research and ratings by Barron's. View CRSP revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.Casper Sleep Inc. (NYSE:CSPR) announced its quarterly earnings results on Monday, November, 15th. The company reported ($0.61) earnings per share for the quarter, missing the consensus estimate of ($0.43) by $0.18. The company had revenue of $156.50 million for the quarter, compared to analyst estimates of $156.15 million.For Vaxart stock forecast for 2033 (10 year), 10 predictions are offered for each month of 2033 with average Vaxart stock forecast of $16.43, a high forecast of $18.46, and a low forecast of $12.03. The average Vaxart stock forecast 2033 represents a 2389.86% increase from the last price of $0.660000026226044. Please, see more forecasts below.Instagram:https://instagram. buy crypto with cash appfunded prop firmsfinancial advisors spokanehighest tesla stock price Nov 17, 2022 · With that in mind, let's look at two gene-editing-focused biotechs that could perform substantially better next year: CRISPR Therapeutics ( CRSP -6.39%) and Bluebird Bio ( BLUE -4.44%). These ... CRISPR Therapeutics AG research and ratings by Barron's. View CRSP revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. best petroleum etfthimble customer service number 3 equities research analysts have issued 12 month price objectives for Cameco's shares. Their CCJ share price targets range from $25.00 to $56.00. On average, they expect the company's share price to reach $35.33 in the next twelve months. This suggests that the stock has a possible downside of 22.2%. mutual funds brokers Jul 6, 2023 · The stock is covered by 27 analysts and has a consensus price target of $83.78 which would be a 48% gain from the stock’s price as of this writing. Vertex Pharmaceuticals (VRTX) Source: Pavel ... CRISPR Therapeutics AG analyst ratings, historical stock prices, earnings estimates & actuals. CRSP.US updated stock price target summary ... FY 2025. CRSP will ...Discover historical prices for CRSP stock on Yahoo Finance. View daily, weekly or monthly format back to when CRISPR Therapeutics AG stock was issued.